25 XP   0   0   10

Berry Genomics Co Ltd
Buy, Hold or Sell?

Let's analyse Berry Genomics Co Ltd together

PenkeI guess you are interested in Berry Genomics Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Berry Genomics Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Berry Genomics Co Ltd

I send you an email if I find something interesting about Berry Genomics Co Ltd.

Quick analysis of Berry Genomics Co Ltd (30 sec.)










What can you expect buying and holding a share of Berry Genomics Co Ltd? (30 sec.)

How much money do you get?

How much money do you get?
¥0.03
When do you have the money?
1 year
How often do you get paid?
90.0%

What is your share worth?

Current worth
¥6.57
Expected worth in 1 year
¥4.38
How sure are you?
80.0%

+ What do you gain per year?

Total Gains per Share
¥-1.99
Return On Investment
-26.8%

For what price can you sell your share?

Current Price per Share
¥7.44
Expected price per share
¥5.4 - ¥13.16
How sure are you?
50%

1. Valuation of Berry Genomics Co Ltd (5 min.)




Live pricePrice per Share (EOD)

¥7.44

Intrinsic Value Per Share

¥-2.67 - ¥3.09

Total Value Per Share

¥3.90 - ¥9.66

2. Growth of Berry Genomics Co Ltd (5 min.)




Is Berry Genomics Co Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$321.9m$348.7m-$26.8m-8.3%

How much money is Berry Genomics Co Ltd making?

Current yearPrevious yearGrowGrow %
Making money-$35.2m-$15.3m-$19.8m-56.5%
Net Profit Margin-18.6%-7.8%--

How much money comes from the company's main activities?

3. Financial Health of Berry Genomics Co Ltd (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#170 / 1016

Most Revenue
#75 / 1016

Most Profit
#829 / 1016

Most Efficient
#494 / 1016

What can you expect buying and holding a share of Berry Genomics Co Ltd? (5 min.)

Welcome investor! Berry Genomics Co Ltd's management wants to use your money to grow the business. In return you get a share of Berry Genomics Co Ltd.

What can you expect buying and holding a share of Berry Genomics Co Ltd?

First you should know what it really means to hold a share of Berry Genomics Co Ltd. And how you can make/lose money.

Speculation

The Price per Share of Berry Genomics Co Ltd is ¥7.44. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Berry Genomics Co Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Berry Genomics Co Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥6.57. Based on the TTM, the Book Value Change Per Share is ¥-0.55 per quarter. Based on the YOY, the Book Value Change Per Share is ¥0.29 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.05 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Berry Genomics Co Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps-0.10-1.3%-0.10-1.3%-0.04-0.6%0.040.5%0.040.5%
Usd Book Value Change Per Share-0.08-1.0%-0.08-1.0%0.040.5%0.060.8%0.091.2%
Usd Dividend Per Share0.010.1%0.010.1%0.010.1%0.010.1%0.000.0%
Usd Total Gains Per Share-0.07-0.9%-0.07-0.9%0.050.6%0.070.9%0.091.2%
Usd Price Per Share1.58-1.58-2.68-3.80-4.04-
Price to Earnings Ratio-15.88--15.88--62.08-12.31-113.07-
Price-to-Total Gains Ratio-22.89--22.89-56.60-44.74-71.99-
Price to Book Ratio1.74-1.74-2.73-4.28-22.56-
Price-to-Total Gains Ratio-22.89--22.89-56.60-44.74-71.99-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.028208
Number of shares972
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.010.01
Usd Book Value Change Per Share-0.080.06
Usd Total Gains Per Share-0.070.07
Gains per Quarter (972 shares)-66.9764.02
Gains per Year (972 shares)-267.90256.10
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
127-295-27823233246
253-589-54646466502
380-884-81469699758
4107-1178-1082929321014
5133-1473-135011511651270
6160-1767-161813913981526
7186-2062-188616216311782
8213-2356-215418518642038
9240-2651-242220820972294
10266-2945-269023123302550

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%1.02.00.033.3%3.02.00.060.0%7.02.01.070.0%16.02.05.069.6%
Book Value Change Per Share0.01.00.00.0%2.01.00.066.7%4.01.00.080.0%7.03.00.070.0%16.07.00.069.6%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%9.00.01.090.0%22.00.01.095.7%
Total Gains per Share0.01.00.00.0%2.01.00.066.7%4.01.00.080.0%8.02.00.080.0%17.06.00.073.9%

Fundamentals of Berry Genomics Co Ltd

About Berry Genomics Co Ltd

Berry Genomics Co.,Ltd, a genomics and life science company, develops and commercializes of genetic test technologies in clinical applications in China. The company offers non-invasive DNA prenatal testing service, genetic disease testing, tumor genetic testing, NextSeq CN500 gene sequencer, and laboratory solutions. It also provides technology services, such as human genome sequencing, transcriptional regulation, single cell/spatial sequencing, animal and plant genome resequencing, genome denovo sequencing, and microbial sequencing, as well as big data services. The company serves various organizations and facilities, including hospitals, research institutions, universities, and enterprises throughout Mainland China, Hong Kong, Macao, Taiwan, Southeast Asia, the Middle East, and Australia. The company was founded in 1997 and is headquartered in Beijing, China.

Fundamental data was last updated by Penke on 2024-04-13 18:11:02.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Berry Genomics Co Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Berry Genomics Co Ltd earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Berry Genomics Co Ltd to the Biotechnology industry mean.
  • A Net Profit Margin of -18.6% means that ¥-0.19 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Berry Genomics Co Ltd:

  • The MRQ is -18.6%. The company is making a huge loss. -2
  • The TTM is -18.6%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-18.6%TTM-18.6%0.0%
TTM-18.6%YOY-7.8%-10.8%
TTM-18.6%5Y6.0%-24.6%
5Y6.0%10Y6.1%-0.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-18.6%-197.2%+178.6%
TTM-18.6%-210.4%+191.8%
YOY-7.8%-279.3%+271.5%
5Y6.0%-436.8%+442.8%
10Y6.1%-599.3%+605.4%
1.1.2. Return on Assets

Shows how efficient Berry Genomics Co Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Berry Genomics Co Ltd to the Biotechnology industry mean.
  • -8.0% Return on Assets means that Berry Genomics Co Ltd generated ¥-0.08 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Berry Genomics Co Ltd:

  • The MRQ is -8.0%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -8.0%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-8.0%TTM-8.0%0.0%
TTM-8.0%YOY-3.1%-4.8%
TTM-8.0%5Y4.1%-12.0%
5Y4.1%10Y3.8%+0.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-8.0%-13.6%+5.6%
TTM-8.0%-12.9%+4.9%
YOY-3.1%-11.9%+8.8%
5Y4.1%-14.2%+18.3%
10Y3.8%-16.2%+20.0%
1.1.3. Return on Equity

Shows how efficient Berry Genomics Co Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Berry Genomics Co Ltd to the Biotechnology industry mean.
  • -11.1% Return on Equity means Berry Genomics Co Ltd generated ¥-0.11 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Berry Genomics Co Ltd:

  • The MRQ is -11.1%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -11.1%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-11.1%TTM-11.1%0.0%
TTM-11.1%YOY-4.5%-6.6%
TTM-11.1%5Y4.8%-15.9%
5Y4.8%10Y4.6%+0.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-11.1%-17.0%+5.9%
TTM-11.1%-16.1%+5.0%
YOY-4.5%-15.4%+10.9%
5Y4.8%-20.0%+24.8%
10Y4.6%-21.1%+25.7%

1.2. Operating Efficiency of Berry Genomics Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Berry Genomics Co Ltd is operating .

  • Measures how much profit Berry Genomics Co Ltd makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Berry Genomics Co Ltd to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated ¥0.00  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Berry Genomics Co Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-3.3%+3.3%
TTM-5Y12.2%-12.2%
5Y12.2%10Y9.6%+2.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--286.1%+286.1%
TTM--224.4%+224.4%
YOY-3.3%-288.4%+285.1%
5Y12.2%-475.2%+487.4%
10Y9.6%-624.7%+634.3%
1.2.2. Operating Ratio

Measures how efficient Berry Genomics Co Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 1.59 means that the operating costs are ¥1.59 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Berry Genomics Co Ltd:

  • The MRQ is 1.590. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.590. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.590TTM1.5900.000
TTM1.590YOY1.541+0.049
TTM1.5905Y1.343+0.246
5Y1.34310Y1.313+0.031
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.5902.997-1.407
TTM1.5903.247-1.657
YOY1.5413.766-2.225
5Y1.3435.675-4.332
10Y1.3137.857-6.544

1.3. Liquidity of Berry Genomics Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Berry Genomics Co Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 2.45 means the company has ¥2.45 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Berry Genomics Co Ltd:

  • The MRQ is 2.450. The company is able to pay all its short-term debts. +1
  • The TTM is 2.450. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.450TTM2.4500.000
TTM2.450YOY2.481-0.030
TTM2.4505Y3.736-1.286
5Y3.73610Y3.704+0.032
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.4503.930-1.480
TTM2.4504.251-1.801
YOY2.4815.436-2.955
5Y3.7366.045-2.309
10Y3.7046.363-2.659
1.3.2. Quick Ratio

Measures if Berry Genomics Co Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Berry Genomics Co Ltd to the Biotechnology industry mean.
  • A Quick Ratio of 1.50 means the company can pay off ¥1.50 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Berry Genomics Co Ltd:

  • The MRQ is 1.503. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 1.503. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ1.503TTM1.5030.000
TTM1.503YOY1.492+0.010
TTM1.5035Y1.945-0.442
5Y1.94510Y2.002-0.057
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.5033.629-2.126
TTM1.5034.065-2.562
YOY1.4925.397-3.905
5Y1.9455.993-4.048
10Y2.0026.277-4.275

1.4. Solvency of Berry Genomics Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Berry Genomics Co Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Berry Genomics Co Ltd to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.27 means that Berry Genomics Co Ltd assets are financed with 27.2% credit (debt) and the remaining percentage (100% - 27.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Berry Genomics Co Ltd:

  • The MRQ is 0.272. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.272. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.272TTM0.2720.000
TTM0.272YOY0.283-0.011
TTM0.2725Y0.230+0.042
5Y0.23010Y0.358-0.128
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2720.332-0.060
TTM0.2720.334-0.062
YOY0.2830.268+0.015
5Y0.2300.366-0.136
10Y0.3580.390-0.032
1.4.2. Debt to Equity Ratio

Measures if Berry Genomics Co Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Berry Genomics Co Ltd to the Biotechnology industry mean.
  • A Debt to Equity ratio of 37.9% means that company has ¥0.38 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Berry Genomics Co Ltd:

  • The MRQ is 0.379. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.379. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.379TTM0.3790.000
TTM0.379YOY0.400-0.021
TTM0.3795Y0.311+0.067
5Y0.31110Y1.056-0.744
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3790.381-0.002
TTM0.3790.390-0.011
YOY0.4000.334+0.066
5Y0.3110.434-0.123
10Y1.0560.466+0.590

2. Market Valuation of Berry Genomics Co Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Berry Genomics Co Ltd generates.

  • Above 15 is considered overpriced but always compare Berry Genomics Co Ltd to the Biotechnology industry mean.
  • A PE ratio of -15.88 means the investor is paying ¥-15.88 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Berry Genomics Co Ltd:

  • The EOD is -10.355. Based on the earnings, the company is expensive. -2
  • The MRQ is -15.881. Based on the earnings, the company is expensive. -2
  • The TTM is -15.881. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-10.355MRQ-15.881+5.526
MRQ-15.881TTM-15.8810.000
TTM-15.881YOY-62.078+46.197
TTM-15.8815Y12.305-28.186
5Y12.30510Y113.065-100.760
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-10.355-2.315-8.040
MRQ-15.881-2.560-13.321
TTM-15.881-2.664-13.217
YOY-62.078-4.122-57.956
5Y12.305-6.258+18.563
10Y113.065-6.108+119.173
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Berry Genomics Co Ltd:

  • The EOD is -50.608. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -77.613. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -77.613. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-50.608MRQ-77.613+27.005
MRQ-77.613TTM-77.6130.000
TTM-77.613YOY-28.350-49.263
TTM-77.6135Y-4,252.067+4,174.455
5Y-4,252.06710Y-2,137.737-2,114.330
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-50.608-3.067-47.541
MRQ-77.613-3.251-74.362
TTM-77.613-3.545-74.068
YOY-28.350-5.595-22.755
5Y-4,252.067-8.315-4,243.752
10Y-2,137.737-8.708-2,129.029
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Berry Genomics Co Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 1.74 means the investor is paying ¥1.74 for each ¥1 in book value.

Let's take a look of the Price to Book Ratio trends of Berry Genomics Co Ltd:

  • The EOD is 1.133. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.737. Based on the equity, the company is underpriced. +1
  • The TTM is 1.737. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.133MRQ1.737-0.604
MRQ1.737TTM1.7370.000
TTM1.737YOY2.726-0.989
TTM1.7375Y4.278-2.541
5Y4.27810Y22.563-18.286
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD1.1331.905-0.772
MRQ1.7372.111-0.374
TTM1.7372.095-0.358
YOY2.7262.836-0.110
5Y4.2783.443+0.835
10Y22.5633.794+18.769
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Berry Genomics Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.548-0.5480%0.286-292%0.434-226%0.622-188%
Book Value Per Share--6.5696.5690%7.117-8%6.523+1%4.063+62%
Current Ratio--2.4502.4500%2.481-1%3.736-34%3.704-34%
Debt To Asset Ratio--0.2720.2720%0.283-4%0.230+18%0.358-24%
Debt To Equity Ratio--0.3790.3790%0.400-5%0.311+22%1.056-64%
Dividend Per Share--0.0500.0500%0.057-13%0.043+15%0.024+106%
Eps---0.718-0.7180%-0.313-57%0.284-353%0.265-371%
Free Cash Flow Per Share---0.147-0.1470%-0.684+365%-0.236+61%-0.245+67%
Free Cash Flow To Equity Per Share---0.147-0.1470%-0.558+279%-0.079-46%-0.016-89%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%0.900+11%
Intrinsic Value_10Y_max--3.088--------
Intrinsic Value_10Y_min---2.667--------
Intrinsic Value_1Y_max---0.115--------
Intrinsic Value_1Y_min---0.254--------
Intrinsic Value_3Y_max---0.022--------
Intrinsic Value_3Y_min---0.778--------
Intrinsic Value_5Y_max--0.461--------
Intrinsic Value_5Y_min---1.317--------
Market Cap2630196180.480-54%4046052919.6504046052919.6500%6879353781.000-41%9742441535.010-58%10364335513.438-61%
Net Profit Margin---0.186-0.1860%-0.078-58%0.060-410%0.061-406%
Operating Margin----0%-0.0330%0.122-100%0.096-100%
Operating Ratio--1.5901.5900%1.541+3%1.343+18%1.313+21%
Pb Ratio1.133-53%1.7371.7370%2.726-36%4.278-59%22.563-92%
Pe Ratio-10.355+35%-15.881-15.8810%-62.078+291%12.305-229%113.065-114%
Price Per Share7.440-53%11.41011.4100%19.400-41%27.474-58%29.258-61%
Price To Free Cash Flow Ratio-50.608+35%-77.613-77.6130%-28.350-63%-4252.067+5379%-2137.737+2654%
Price To Total Gains Ratio-14.922+35%-22.885-22.8850%56.595-140%44.742-151%71.988-132%
Quick Ratio--1.5031.5030%1.492+1%1.945-23%2.002-25%
Return On Assets---0.080-0.0800%-0.031-60%0.041-295%0.038-307%
Return On Equity---0.111-0.1110%-0.045-60%0.048-329%0.046-342%
Total Gains Per Share---0.499-0.4990%0.343-245%0.477-205%0.646-177%
Usd Book Value--321913107.889321913107.8890%348775623.646-8%319652325.936+1%199054299.986+62%
Usd Book Value Change Per Share---0.076-0.0760%0.039-292%0.060-226%0.086-188%
Usd Book Value Per Share--0.9080.9080%0.984-8%0.901+1%0.561+62%
Usd Dividend Per Share--0.0070.0070%0.008-13%0.006+15%0.003+106%
Usd Eps---0.099-0.0990%-0.043-57%0.039-353%0.037-371%
Usd Free Cash Flow---7204550.830-7204550.8300%-33535606.570+365%-11574605.884+61%-12014431.394+67%
Usd Free Cash Flow Per Share---0.020-0.0200%-0.095+365%-0.033+61%-0.034+67%
Usd Free Cash Flow To Equity Per Share---0.020-0.0200%-0.077+279%-0.011-46%-0.002-89%
Usd Market Cap363493112.142-54%559164513.496559164513.4960%950726692.534-41%1346405420.138-58%1432351167.957-61%
Usd Price Per Share1.028-53%1.5771.5770%2.681-41%3.797-58%4.043-61%
Usd Profit---35210401.250-35210401.2500%-15315125.379-57%13924431.720-353%10821241.379-425%
Usd Revenue--189058596.682189058596.6820%196545403.322-4%204204436.409-7%134765359.671+40%
Usd Total Gains Per Share---0.069-0.0690%0.047-245%0.066-205%0.089-177%
 EOD+3 -5MRQTTM+0 -0YOY+11 -235Y+11 -2410Y+15 -21

3.2. Fundamental Score

Let's check the fundamental score of Berry Genomics Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-10.355
Price to Book Ratio (EOD)Between0-11.133
Net Profit Margin (MRQ)Greater than0-0.186
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than11.503
Current Ratio (MRQ)Greater than12.450
Debt to Asset Ratio (MRQ)Less than10.272
Debt to Equity Ratio (MRQ)Less than10.379
Return on Equity (MRQ)Greater than0.15-0.111
Return on Assets (MRQ)Greater than0.05-0.080
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of Berry Genomics Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5038.335
Ma 20Greater thanMa 509.155
Ma 50Greater thanMa 1008.439
Ma 100Greater thanMa 20010.262
OpenGreater thanClose7.440
Total1/5 (20.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2018-12-312019-12-312020-12-312021-12-312022-12-31
EBITDA  379,293149,318528,611-191,028337,582-331,2676,315-169,216-162,900
Operating Income  358,77795,457454,234-197,308256,927-240,77916,148-39,392-23,245



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets3,200,863
Total Liabilities871,535
Total Stockholder Equity2,301,387
 As reported
Total Liabilities 871,535
Total Stockholder Equity+ 2,301,387
Total Assets = 3,200,863

Assets

Total Assets3,200,863
Total Current Assets1,726,866
Long-term Assets1,473,997
Total Current Assets
Cash And Cash Equivalents 333,563
Short-term Investments 4,505
Net Receivables 1,054,380
Inventory 230,948
Other Current Assets 46,018
Total Current Assets  (as reported)1,726,866
Total Current Assets  (calculated)1,669,415
+/- 57,451
Long-term Assets
Property Plant Equipment 1,100,829
Goodwill 13,434
Intangible Assets 77,505
Long-term Assets Other 26,665
Long-term Assets  (as reported)1,473,997
Long-term Assets  (calculated)1,218,433
+/- 255,564

Liabilities & Shareholders' Equity

Total Current Liabilities704,720
Long-term Liabilities166,815
Total Stockholder Equity2,301,387
Total Current Liabilities
Short Long Term Debt 203,690
Accounts payable 278,902
Other Current Liabilities 9,863
Total Current Liabilities  (as reported)704,720
Total Current Liabilities  (calculated)492,455
+/- 212,265
Long-term Liabilities
Long term Debt 126,600
Capital Lease Obligations Min Short Term Debt4,884
Long-term Liabilities  (as reported)166,815
Long-term Liabilities  (calculated)131,484
+/- 35,331
Total Stockholder Equity
Retained Earnings 684,167
Total Stockholder Equity (as reported)2,301,387
Total Stockholder Equity (calculated)684,167
+/- 1,617,219
Other
Capital Stock354,606
Common Stock Shares Outstanding 354,606
Net Invested Capital 2,631,677
Net Working Capital 1,022,147
Property Plant and Equipment Gross 1,583,047



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-312000-12-31
> Total Assets 
332,388
357,291
242,097
258,410
278,525
233,847
244,650
226,041
311,276
366,045
383,266
355,226
341,018
410,084
445,854
1,004,042
548,045
1,806,398
2,177,997
3,068,877
3,243,969
3,519,722
3,200,863
3,200,8633,519,7223,243,9693,068,8772,177,9971,806,398548,0451,004,042445,854410,084341,018355,226383,266366,045311,276226,041244,650233,847278,525258,410242,097357,291332,388
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
787,822
720,642
1,102,709
1,357,202
1,852,594
2,008,047
1,906,580
1,726,866
1,726,8661,906,5802,008,0471,852,5941,357,2021,102,709720,642787,822000000000000000
       Cash And Cash Equivalents 
33,983
22,010
26,718
43,762
35,295
11,123
6,927
4,927
78,537
64,192
101,306
69,462
86,665
101,214
101,599
299,917
74,011
411,625
423,619
411,490
629,308
417,889
333,563
333,563417,889629,308411,490423,619411,62574,011299,917101,599101,21486,66569,462101,30664,19278,5374,9276,92711,12335,29543,76226,71822,01033,983
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
250,000
111,000
0
0
6,430
3,815
3,815
4,505
4,5053,8153,8156,43000111,000250,000000000000000000
       Net Receivables 
106,406
96,380
46,172
58,124
70,627
70,516
85,714
75,859
75,731
154,008
131,009
126,322
81,280
84,960
103,850
164,052
302,051
522,110
654,048
847,326
1,069,887
1,143,230
1,054,380
1,054,3801,143,2301,069,887847,326654,048522,110302,051164,052103,85084,96081,280126,322131,009154,00875,73175,85985,71470,51670,62758,12446,17296,380106,406
       Other Current Assets 
6,242
74,008
3,527
3,611
9,706
11,199
15,221
12,600
7,884
5,908
2,338
7,713
7,730
5,819
8,148
23,224
39,716
59,349
70,209
111,751
74,649
99,329
46,018
46,01899,32974,649111,75170,20959,34939,71623,2248,1485,8197,7307,7132,3385,9087,88412,60015,22111,1999,7063,6113,52774,0086,242
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
298,460
703,689
820,794
1,216,283
1,235,922
1,613,142
1,473,997
1,473,9971,613,1421,235,9221,216,283820,794703,689298,4600000000000000000
       Property Plant Equipment 
126,465
121,107
124,262
115,343
102,407
94,943
96,440
88,920
89,292
83,464
83,035
80,885
95,026
98,720
72,911
170,923
435,388
538,174
585,061
811,022
909,279
1,130,745
1,100,829
1,100,8291,130,745909,279811,022585,061538,174435,388170,92372,91198,72095,02680,88583,03583,46489,29288,92096,44094,943102,407115,343124,262121,107126,465
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
13,434
13,434
13,434
13,434
13,434
13,434
13,434
13,434
13,43413,43413,43413,43413,43413,43413,43413,434000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
17,375
22,666
84,868
0
0
0
0
000084,86822,66617,3750000000000000000
       Intangible Assets 
2,163
1,803
652
1,055
648
567
486
405
16,924
16,843
16,762
16,681
16,600
16,600
16,172
9,589
15,497
16,041
81,631
85,230
70,691
74,023
77,505
77,50574,02370,69185,23081,63116,04115,4979,58916,17216,60016,60016,68116,76216,84316,9244054865676481,0556521,8032,163
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6,503
91,120
19,312
62,039
19,003
27,046
26,665
26,66527,04619,00362,03919,31291,1206,5030000000000000000
> Total Liabilities 
125,329
195,812
133,224
146,301
165,774
135,258
144,868
131,536
206,934
251,536
261,043
232,727
217,338
289,087
315,825
91,102
433,969
245,935
235,676
721,830
821,521
996,020
871,535
871,535996,020821,521721,830235,676245,935433,96991,102315,825289,087217,338232,727261,043251,536206,934131,536144,868135,258165,774146,301133,224195,812125,329
   > Total Current Liabilities 
115,329
195,812
133,224
146,301
165,774
135,258
144,868
131,536
206,934
251,536
261,043
232,727
216,638
288,287
292,694
91,102
141,915
238,135
225,380
449,719
556,430
768,577
704,720
704,720768,577556,430449,719225,380238,135141,91591,102292,694288,287216,638232,727261,043251,536206,934131,536144,868135,258165,774146,301133,224195,812115,329
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
74,056
29,257
0
11,266
0
0
0
00011,266029,25774,0560000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
74,056
29,257
0
11,266
123,105
190,538
203,690
203,690190,538123,10511,266029,25774,0560000000000000000
       Accounts payable 
36,026
23,788
23,238
26,219
32,332
34,285
38,172
41,424
92,894
129,596
168,897
139,440
110,426
136,884
145,007
23,498
48,483
86,827
82,835
213,268
243,288
339,929
278,902
278,902339,929243,288213,26882,83586,82748,48323,498145,007136,884110,426139,440168,897129,59692,89441,42438,17234,28532,33226,21923,23823,78836,026
       Other Current Liabilities 
24,253
16,224
16,186
11,782
19,962
14,100
18,042
11,573
12,580
15,440
13,126
14,707
41,566
36,713
64,398
60,976
44,806
76,252
85,712
171,962
115,995
162,506
9,863
9,863162,506115,995171,96285,71276,25244,80660,97664,39836,71341,56614,70713,12615,44012,58011,57318,04214,10019,96211,78216,18616,22424,253
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
148,244
7,801
10,296
272,111
265,092
227,443
166,815
166,815227,443265,092272,11110,2967,801148,2440000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
700
800
23,131
91,328
8,493
7,801
10,296
27,308
28,755
28,121
0
028,12128,75527,30810,2967,8018,49391,32823,131800700000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
17,518
18,708
21,514
29,666
44,161
46,806
46,711
0
046,71146,80644,16129,66621,51418,70817,518000000000000000
> Total Stockholder Equity
203,512
159,252
108,872
112,109
112,751
98,589
99,782
94,505
97,530
107,983
116,196
116,697
118,049
115,439
130,028
899,083
114,076
1,536,564
1,903,440
2,328,393
2,388,439
2,490,193
2,301,387
2,301,3872,490,1932,388,4392,328,3931,903,4401,536,564114,076899,083130,028115,439118,049116,697116,196107,98397,53094,50599,78298,589112,751112,109108,872159,252203,512
   Common Stock
108,000
151,200
151,200
151,200
151,200
151,200
151,200
151,200
151,200
151,200
151,200
151,200
151,200
151,200
151,200
351,449
203,406
354,606
354,606
354,606
354,606
354,606
0
0354,606354,606354,606354,606354,606203,406351,449151,200151,200151,200151,200151,200151,200151,200151,200151,200151,200151,200151,200151,200151,200108,000
   Retained Earnings 
39,572
0
0
0
0
0
0
0
0
0
0
0
0
0
0
127,295
111,237
301,292
569,384
934,016
1,130,614
1,019,795
684,167
684,1671,019,7951,130,614934,016569,384301,292111,237127,2950000000000000039,572
   Capital Surplus 00000000000000000000000
   Treasury Stock00000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
462
1,539
-340
7,252
14,923
2,730
630
0
06302,73014,9237,252-3401,539462000000000000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue1,180,272
Cost of Revenue-683,888
Gross Profit496,383496,383
 
Operating Income (+$)
Gross Profit496,383
Operating Expense-1,300,531
Operating Income-120,259-804,148
 
Operating Expense (+$)
Research Development101,930
Selling General Administrative335,442
Selling And Marketing Expenses-
Operating Expense1,300,531437,371
 
Net Interest Income (+$)
Interest Income-
Interest Expense--
Other Finance Cost-14,307
Net Interest Income-14,307
 
Pretax Income (+$)
Operating Income-120,259
Net Interest Income-14,307
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-400,274-120,259
EBIT - interestExpense = 0
-373,541
-373,541
Interest Expense-
Earnings Before Interest and Taxes (EBIT)--400,274
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-400,274
Tax Provision--28,670
Net Income From Continuing Ops-371,604-371,604
Net Income-373,541
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-14,307
 

Technical Analysis of Berry Genomics Co Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Berry Genomics Co Ltd. The general trend of Berry Genomics Co Ltd is BEARISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Berry Genomics Co Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-85.7%) Bearish trend (85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Berry Genomics Co Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 7.8 < 7.8 < 13.16.

The bearish price targets are: 5.4.

Tweet this
Berry Genomics Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Berry Genomics Co Ltd. The current mas is .

The long score for the Moving Averages is 1/14.
The longshort score for the Moving Averages is -12/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Berry Genomics Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Berry Genomics Co Ltd. The current macd is -0.43123927.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Berry Genomics Co Ltd price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Berry Genomics Co Ltd. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Berry Genomics Co Ltd price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Berry Genomics Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartBerry Genomics Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Berry Genomics Co Ltd. The current adx is 20.86.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Berry Genomics Co Ltd shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Berry Genomics Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Berry Genomics Co Ltd. The current sar is 8.98758901.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Berry Genomics Co Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Berry Genomics Co Ltd. The current rsi is 38.34. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Berry Genomics Co Ltd Daily Relative Strength Index (RSI) ChartBerry Genomics Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Berry Genomics Co Ltd. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Berry Genomics Co Ltd price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Berry Genomics Co Ltd Daily Stochastic Oscillator ChartBerry Genomics Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Berry Genomics Co Ltd. The current cci is -113.97427513.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Berry Genomics Co Ltd Daily Commodity Channel Index (CCI) ChartBerry Genomics Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Berry Genomics Co Ltd. The current cmo is -31.26530202.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Berry Genomics Co Ltd Daily Chande Momentum Oscillator (CMO) ChartBerry Genomics Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Berry Genomics Co Ltd. The current willr is -76.77419355.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Berry Genomics Co Ltd is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Berry Genomics Co Ltd Daily Williams %R ChartBerry Genomics Co Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Berry Genomics Co Ltd.

Berry Genomics Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Berry Genomics Co Ltd. The current atr is 0.60652497.

Berry Genomics Co Ltd Daily Average True Range (ATR) ChartBerry Genomics Co Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Berry Genomics Co Ltd. The current obv is -256,872,471.

Berry Genomics Co Ltd Daily On-Balance Volume (OBV) ChartBerry Genomics Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Berry Genomics Co Ltd. The current mfi is 53.44.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Berry Genomics Co Ltd Daily Money Flow Index (MFI) ChartBerry Genomics Co Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Berry Genomics Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-21ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-22STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-11-23RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-11-27STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-28BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-29RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2023-11-30STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-01STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-05CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-06RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-08STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-11STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-13WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-15CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-18STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-21DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-25MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-26STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-27MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-28MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-04MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-05STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-16CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-19STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-22ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-24MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-25RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-01-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-30SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-31BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-19ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-20RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-02-21SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-26CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-27WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-29DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-03-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-06DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-07SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-15CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-19SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-20ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-21STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-22MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-25RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-27SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-28CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-29CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-01STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-02MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-03WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-16STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-17STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Berry Genomics Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Berry Genomics Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5038.335
Ma 20Greater thanMa 509.155
Ma 50Greater thanMa 1008.439
Ma 100Greater thanMa 20010.262
OpenGreater thanClose7.440
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Berry Genomics Co Ltd with someone you think should read this too:
  • Are you bullish or bearish on Berry Genomics Co Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Berry Genomics Co Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Berry Genomics Co Ltd

I send you an email if I find something interesting about Berry Genomics Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Berry Genomics Co Ltd.

Receive notifications about Berry Genomics Co Ltd in your mailbox!